GPT Healthcare Ltd.

128.14

-0.1 (0%)growUp

GPTHEALTH Share Price
As on January 28, 2026
SectorHealthcare
IndustryHEALTHCARE SERVICES
Basic IndustryHOSPITAL
Market Cap1,057 Cr
P/E Ratio24.55
Dividend Yield0.55 %
Trendline Performance

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open129.75
High129.75
NSE SymbolGPTHEALTH
Close128.14
Low126.5
BSE Symbol544131
Previous Years High/Low
1 Year High185
3 Year High219.9
5 Year High219.9
1 Year Low124.9
3 Year Low124.9
5 Year Low124.9

Technicals


IndicatorsValueSignal
5-DMA129.1Bearish
10-DMA131.66Bearish
20-DMA135.42Bearish
50-DMA138.59Bearish
100-DMA144.01Bearish
200-DMA151.11Bearish

Historical Performance


1 Year
-20.5%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


ParticularsMar-2022Mar-2021Mar-2020Mar-2019
Other Income50614230
Operating Profit788551400398
Interest112137141105
Depreciation13612511190
Profit Before Tax541289148204
Consolidated Net Profit417211110150
Adjusted EPS5323
Compounded Sales Growth
10 Years:14.4
5 Years:14.4
3 Years:14.4
TTM:6.8
Compounded Profit Growth
10 Years:22.8
5 Years:22.8
3 Years:22.8
TTM:14.6
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:-21.6
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:2
last year:5.2

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


ParticularsMar-2022Mar-2021Mar-2020Mar-2019
Share Capital799579579579
Total Reserves783759689579
Long-Term Borrowings------------
Total Non-Current Liabilities9291,1681,130779
Other Current Liabilities321265215168
Short Term Borrowings34207498
Total Liabilities3,1953,1063,0452,490
Capital Work in Progress7318320
Long Term Loans & Advances7837132107
Currents Investments54---------
Short Term Loans and Advances432532341261
Total Current Assets857863626473
Total Assets3,1953,1063,0452,490
Adjusted Book Value20171614
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a moderate PE of 24.55, suggesting fair valuation relative to earnings.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -36.2%, indicating poor shareholder returns.
  • The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported an EBITDA of ₹788 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹3374 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 783778.8
No. of Shares: 6117 (Approx)
Performance:-21.6%
P/L: ₹-216221.2
NIFTY Performance: 9.4%
1 day Top Gainers
SymbolChange%
TEJASNET339.05(15%)
DATAPATTNS2610.6(14%)
HINDCOPPER633.4(13%)
OLECTRA1088.4(10%)
SCHNEIDER697.7(10%)
1 Day Top Losers
SymbolChange%
RADICO2746.8(-6%)
HOMEFIRST1190.9(-5%)
TATACONSUM1131.8(-5%)
ASIANPAINT2511.8(-4%)
VMM119.86(-4%)
BERGEPAINT478.85(-3%)
EMCURE1435.8(-3%)
AIIL502.1(-3%)

Top Performing Stocks from the same sector


Lotus Eye Hospital And Institute Ltd.

5.1%

134.65

1 Month Performance

Take Solutions Ltd.

0.9%

38.45

1 Month Performance

Sastasundar Ventures Ltd.

0%

301.15

1 Month Performance

Dr. Lal Pathlabs Ltd.

-0.3%

1400.4

1 Month Performance

Thyrocare Technologies Ltd.

-0.4%

458.7

1 Month Performance

Krsnaa Diagnostics Ltd.

-2%

716.75

1 Month Performance

Krishna Institute of Medical Sciences Ltd

-2.7%

609.65

1 Month Performance

Suraksha Diagnostic Ltd.

-2.8%

263.3

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month